[1]
S. BOONSOM, S. VANNAPRASAHT, and Y. PREECHAGOON, “THERAPEUTIC DOSAGE RANGES AND CHRONIC ADVERSE EFFECTS OF TACROLIMUS IN THAI KIDNEY TRANSPLANT PATIENTS”, Int J App Pharm, vol. 13, no. 1, pp. 13–16, Jan. 2021.